nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—ACHE—kidney cancer	0.347	0.63	CbGaD
Rivastigmine—BCHE—kidney cancer	0.204	0.37	CbGaD
Rivastigmine—CYP2D6—Temsirolimus—kidney cancer	0.0411	0.169	CbGbCtD
Rivastigmine—CYP3A4—Everolimus—kidney cancer	0.0386	0.159	CbGbCtD
Rivastigmine—CYP3A4—Temsirolimus—kidney cancer	0.0261	0.108	CbGbCtD
Rivastigmine—CYP2D6—Pazopanib—kidney cancer	0.0216	0.0889	CbGbCtD
Rivastigmine—CYP2D6—Erlotinib—kidney cancer	0.0154	0.0635	CbGbCtD
Rivastigmine—CYP3A4—Pazopanib—kidney cancer	0.0137	0.0566	CbGbCtD
Rivastigmine—CYP2D6—Sorafenib—kidney cancer	0.0125	0.0516	CbGbCtD
Rivastigmine—CYP2D6—Vinblastine—kidney cancer	0.0124	0.051	CbGbCtD
Rivastigmine—CYP3A4—Erlotinib—kidney cancer	0.00978	0.0404	CbGbCtD
Rivastigmine—CYP3A4—Paclitaxel—kidney cancer	0.00896	0.0369	CbGbCtD
Rivastigmine—CYP3A4—Sorafenib—kidney cancer	0.00796	0.0328	CbGbCtD
Rivastigmine—CYP3A4—Vinblastine—kidney cancer	0.00786	0.0324	CbGbCtD
Rivastigmine—CYP3A4—Vincristine—kidney cancer	0.00772	0.0319	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—kidney cancer	0.00759	0.0313	CbGbCtD
Rivastigmine—CYP3A4—Sunitinib—kidney cancer	0.00645	0.0266	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—kidney cancer	0.00483	0.0199	CbGbCtD
Rivastigmine—Pyridostigmine—ACHE—kidney cancer	0.00172	0.337	CrCbGaD
Rivastigmine—Neostigmine—ACHE—kidney cancer	0.0013	0.255	CrCbGaD
Rivastigmine—Pyridostigmine—BCHE—kidney cancer	0.00101	0.198	CrCbGaD
Rivastigmine—Neostigmine—BCHE—kidney cancer	0.000765	0.15	CrCbGaD
Rivastigmine—Neostigmine—ABCB1—kidney cancer	0.0003	0.0589	CrCbGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—MAPK3—kidney cancer	5.18e-05	0.00323	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.12e-05	0.0032	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.08e-05	0.00317	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MUC4—kidney cancer	4.99e-05	0.00312	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—ACHE—kidney cancer	4.98e-05	0.00311	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	4.96e-05	0.0031	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—MAPK1—kidney cancer	4.93e-05	0.00308	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—BCHE—kidney cancer	4.86e-05	0.00304	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ST3GAL2—kidney cancer	4.75e-05	0.00297	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	4.73e-05	0.00295	CbGpPWpGaD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4.67e-05	0.00292	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—CTNNB1—kidney cancer	4.64e-05	0.0029	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—EEF2—kidney cancer	4.64e-05	0.0029	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MUC4—kidney cancer	4.46e-05	0.00278	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ACY1—kidney cancer	4.37e-05	0.00273	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ST3GAL2—kidney cancer	4.24e-05	0.00265	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—CTNNB1—kidney cancer	4.14e-05	0.00259	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—EEF2—kidney cancer	4.14e-05	0.00259	CbGpPWpGaD
Rivastigmine—Body temperature increased—Vincristine—kidney cancer	4.02e-05	0.000217	CcSEcCtD
Rivastigmine—Abdominal pain—Vincristine—kidney cancer	4.02e-05	0.000217	CcSEcCtD
Rivastigmine—Liver function test abnormal—Doxorubicin—kidney cancer	4.01e-05	0.000217	CcSEcCtD
Rivastigmine—Infection—Paclitaxel—kidney cancer	4.01e-05	0.000217	CcSEcCtD
Rivastigmine—Flatulence—Capecitabine—kidney cancer	4e-05	0.000216	CcSEcCtD
Rivastigmine—Dry skin—Doxorubicin—kidney cancer	3.98e-05	0.000215	CcSEcCtD
Rivastigmine—Dysgeusia—Capecitabine—kidney cancer	3.97e-05	0.000215	CcSEcCtD
Rivastigmine—Dizziness—Sunitinib—kidney cancer	3.97e-05	0.000215	CcSEcCtD
Rivastigmine—Feeling abnormal—Gemcitabine—kidney cancer	3.97e-05	0.000215	CcSEcCtD
Rivastigmine—Shock—Paclitaxel—kidney cancer	3.97e-05	0.000215	CcSEcCtD
Rivastigmine—Vomiting—Sorafenib—kidney cancer	3.97e-05	0.000215	CcSEcCtD
Rivastigmine—Abdominal pain upper—Doxorubicin—kidney cancer	3.97e-05	0.000214	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Doxorubicin—kidney cancer	3.97e-05	0.000214	CcSEcCtD
Rivastigmine—Nervous system disorder—Paclitaxel—kidney cancer	3.96e-05	0.000214	CcSEcCtD
Rivastigmine—Hypokalaemia—Doxorubicin—kidney cancer	3.95e-05	0.000214	CcSEcCtD
Rivastigmine—Thrombocytopenia—Paclitaxel—kidney cancer	3.95e-05	0.000214	CcSEcCtD
Rivastigmine—Tachycardia—Paclitaxel—kidney cancer	3.94e-05	0.000213	CcSEcCtD
Rivastigmine—Rash—Sorafenib—kidney cancer	3.94e-05	0.000213	CcSEcCtD
Rivastigmine—Dermatitis—Sorafenib—kidney cancer	3.93e-05	0.000213	CcSEcCtD
Rivastigmine—Back pain—Capecitabine—kidney cancer	3.93e-05	0.000212	CcSEcCtD
Rivastigmine—Breast disorder—Doxorubicin—kidney cancer	3.93e-05	0.000212	CcSEcCtD
Rivastigmine—Skin disorder—Paclitaxel—kidney cancer	3.92e-05	0.000212	CcSEcCtD
Rivastigmine—Headache—Sorafenib—kidney cancer	3.91e-05	0.000211	CcSEcCtD
Rivastigmine—Muscle spasms—Capecitabine—kidney cancer	3.9e-05	0.000211	CcSEcCtD
Rivastigmine—Hyperhidrosis—Paclitaxel—kidney cancer	3.9e-05	0.000211	CcSEcCtD
Rivastigmine—BCHE—Metabolism—ACY1—kidney cancer	3.9e-05	0.00243	CbGpPWpGaD
Rivastigmine—Diarrhoea—Dactinomycin—kidney cancer	3.89e-05	0.00021	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	3.89e-05	0.00243	CbGpPWpGaD
Rivastigmine—Nasopharyngitis—Doxorubicin—kidney cancer	3.89e-05	0.00021	CcSEcCtD
Rivastigmine—Anorexia—Paclitaxel—kidney cancer	3.85e-05	0.000208	CcSEcCtD
Rivastigmine—Gastritis—Doxorubicin—kidney cancer	3.85e-05	0.000208	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.83e-05	0.00239	CbGpPWpGaD
Rivastigmine—Muscular weakness—Doxorubicin—kidney cancer	3.83e-05	0.000207	CcSEcCtD
Rivastigmine—Vision blurred—Capecitabine—kidney cancer	3.83e-05	0.000207	CcSEcCtD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	3.82e-05	0.00239	CbGpPWpGaD
Rivastigmine—Vomiting—Sunitinib—kidney cancer	3.82e-05	0.000206	CcSEcCtD
Rivastigmine—Body temperature increased—Gemcitabine—kidney cancer	3.81e-05	0.000206	CcSEcCtD
Rivastigmine—Tremor—Capecitabine—kidney cancer	3.8e-05	0.000205	CcSEcCtD
Rivastigmine—Rash—Sunitinib—kidney cancer	3.79e-05	0.000205	CcSEcCtD
Rivastigmine—Dermatitis—Sunitinib—kidney cancer	3.79e-05	0.000205	CcSEcCtD
Rivastigmine—Hypotension—Paclitaxel—kidney cancer	3.77e-05	0.000204	CcSEcCtD
Rivastigmine—Ill-defined disorder—Capecitabine—kidney cancer	3.77e-05	0.000204	CcSEcCtD
Rivastigmine—Headache—Sunitinib—kidney cancer	3.76e-05	0.000203	CcSEcCtD
Rivastigmine—Dysphagia—Doxorubicin—kidney cancer	3.76e-05	0.000203	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	3.75e-05	0.00234	CbGpPWpGaD
Rivastigmine—Anaemia—Capecitabine—kidney cancer	3.75e-05	0.000203	CcSEcCtD
Rivastigmine—Hypersensitivity—Vincristine—kidney cancer	3.74e-05	0.000202	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.72e-05	0.00233	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PDHB—kidney cancer	3.71e-05	0.00232	CbGpPWpGaD
Rivastigmine—Nausea—Sorafenib—kidney cancer	3.71e-05	0.0002	CcSEcCtD
Rivastigmine—Pancreatitis—Doxorubicin—kidney cancer	3.68e-05	0.000199	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.68e-05	0.000199	CcSEcCtD
Rivastigmine—Malaise—Capecitabine—kidney cancer	3.66e-05	0.000198	CcSEcCtD
Rivastigmine—Angina pectoris—Doxorubicin—kidney cancer	3.66e-05	0.000198	CcSEcCtD
Rivastigmine—Insomnia—Paclitaxel—kidney cancer	3.65e-05	0.000197	CcSEcCtD
Rivastigmine—Vertigo—Capecitabine—kidney cancer	3.65e-05	0.000197	CcSEcCtD
Rivastigmine—Asthenia—Vincristine—kidney cancer	3.65e-05	0.000197	CcSEcCtD
Rivastigmine—Syncope—Capecitabine—kidney cancer	3.64e-05	0.000197	CcSEcCtD
Rivastigmine—Paraesthesia—Paclitaxel—kidney cancer	3.62e-05	0.000196	CcSEcCtD
Rivastigmine—Vomiting—Dactinomycin—kidney cancer	3.62e-05	0.000195	CcSEcCtD
Rivastigmine—Bronchitis—Doxorubicin—kidney cancer	3.61e-05	0.000195	CcSEcCtD
Rivastigmine—Dyspnoea—Paclitaxel—kidney cancer	3.6e-05	0.000194	CcSEcCtD
Rivastigmine—Somnolence—Paclitaxel—kidney cancer	3.59e-05	0.000194	CcSEcCtD
Rivastigmine—Palpitations—Capecitabine—kidney cancer	3.59e-05	0.000194	CcSEcCtD
Rivastigmine—Rash—Dactinomycin—kidney cancer	3.59e-05	0.000194	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.58e-05	0.00223	CbGpPWpGaD
Rivastigmine—Nausea—Sunitinib—kidney cancer	3.57e-05	0.000193	CcSEcCtD
Rivastigmine—Loss of consciousness—Capecitabine—kidney cancer	3.57e-05	0.000193	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—MME—kidney cancer	3.56e-05	0.00222	CbGpPWpGaD
Rivastigmine—Dyspepsia—Paclitaxel—kidney cancer	3.55e-05	0.000192	CcSEcCtD
Rivastigmine—Cough—Capecitabine—kidney cancer	3.54e-05	0.000191	CcSEcCtD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.53e-05	0.0022	CbGpPWpGaD
Rivastigmine—Dysuria—Doxorubicin—kidney cancer	3.51e-05	0.00019	CcSEcCtD
Rivastigmine—Decreased appetite—Paclitaxel—kidney cancer	3.51e-05	0.00019	CcSEcCtD
Rivastigmine—Hypertension—Capecitabine—kidney cancer	3.5e-05	0.000189	CcSEcCtD
Rivastigmine—ACHE—Metabolism—CCBL1—kidney cancer	3.49e-05	0.00218	CbGpPWpGaD
Rivastigmine—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.49e-05	0.000189	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.49e-05	0.000188	CcSEcCtD
Rivastigmine—Fatigue—Paclitaxel—kidney cancer	3.48e-05	0.000188	CcSEcCtD
Rivastigmine—Diarrhoea—Vincristine—kidney cancer	3.48e-05	0.000188	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—kidney cancer	3.47e-05	0.000187	CcSEcCtD
Rivastigmine—Asthenia—Gemcitabine—kidney cancer	3.46e-05	0.000187	CcSEcCtD
Rivastigmine—Arthralgia—Capecitabine—kidney cancer	3.46e-05	0.000187	CcSEcCtD
Rivastigmine—Chest pain—Capecitabine—kidney cancer	3.46e-05	0.000187	CcSEcCtD
Rivastigmine—Myalgia—Capecitabine—kidney cancer	3.46e-05	0.000187	CcSEcCtD
Rivastigmine—Pain—Paclitaxel—kidney cancer	3.45e-05	0.000187	CcSEcCtD
Rivastigmine—Constipation—Paclitaxel—kidney cancer	3.45e-05	0.000187	CcSEcCtD
Rivastigmine—Anxiety—Capecitabine—kidney cancer	3.44e-05	0.000186	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.43e-05	0.000185	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—kidney cancer	3.43e-05	0.000185	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—kidney cancer	3.42e-05	0.000185	CcSEcCtD
Rivastigmine—Discomfort—Capecitabine—kidney cancer	3.41e-05	0.000184	CcSEcCtD
Rivastigmine—Pruritus—Gemcitabine—kidney cancer	3.41e-05	0.000184	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—kidney cancer	3.4e-05	0.000184	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—kidney cancer	3.39e-05	0.000183	CcSEcCtD
Rivastigmine—Dry mouth—Capecitabine—kidney cancer	3.38e-05	0.000183	CcSEcCtD
Rivastigmine—Nausea—Dactinomycin—kidney cancer	3.38e-05	0.000183	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	3.37e-05	0.00211	CbGpPWpGaD
Rivastigmine—Pneumonia—Doxorubicin—kidney cancer	3.37e-05	0.000182	CcSEcCtD
Rivastigmine—Dizziness—Vincristine—kidney cancer	3.36e-05	0.000182	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—kidney cancer	3.35e-05	0.000181	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—kidney cancer	3.35e-05	0.000181	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—kidney cancer	3.35e-05	0.000181	CcSEcCtD
Rivastigmine—Confusional state—Capecitabine—kidney cancer	3.34e-05	0.00018	CcSEcCtD
Rivastigmine—Feeling abnormal—Paclitaxel—kidney cancer	3.33e-05	0.00018	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.32e-05	0.00208	CbGpPWpGaD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.32e-05	0.000179	CcSEcCtD
Rivastigmine—BCHE—Metabolism—PDHB—kidney cancer	3.31e-05	0.00207	CbGpPWpGaD
Rivastigmine—Oedema—Capecitabine—kidney cancer	3.31e-05	0.000179	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—HSPD1—kidney cancer	3.31e-05	0.00207	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—RPL14—kidney cancer	3.31e-05	0.00207	CbGpPWpGaD
Rivastigmine—Gastrointestinal pain—Paclitaxel—kidney cancer	3.3e-05	0.000178	CcSEcCtD
Rivastigmine—Diarrhoea—Gemcitabine—kidney cancer	3.3e-05	0.000178	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—kidney cancer	3.29e-05	0.000178	CcSEcCtD
Rivastigmine—Infection—Capecitabine—kidney cancer	3.29e-05	0.000178	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—kidney cancer	3.28e-05	0.000177	CcSEcCtD
Rivastigmine—Shock—Capecitabine—kidney cancer	3.26e-05	0.000176	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—kidney cancer	3.25e-05	0.000176	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—kidney cancer	3.25e-05	0.000176	CcSEcCtD
Rivastigmine—Nervous system disorder—Capecitabine—kidney cancer	3.25e-05	0.000176	CcSEcCtD
Rivastigmine—Thrombocytopenia—Capecitabine—kidney cancer	3.24e-05	0.000175	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—BRAF—kidney cancer	3.24e-05	0.00202	CbGpPWpGaD
Rivastigmine—Tachycardia—Capecitabine—kidney cancer	3.23e-05	0.000175	CcSEcCtD
Rivastigmine—Vomiting—Vincristine—kidney cancer	3.23e-05	0.000175	CcSEcCtD
Rivastigmine—Skin disorder—Capecitabine—kidney cancer	3.22e-05	0.000174	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—kidney cancer	3.21e-05	0.000173	CcSEcCtD
Rivastigmine—Urticaria—Paclitaxel—kidney cancer	3.21e-05	0.000173	CcSEcCtD
Rivastigmine—Rash—Vincristine—kidney cancer	3.2e-05	0.000173	CcSEcCtD
Rivastigmine—Hyperhidrosis—Capecitabine—kidney cancer	3.2e-05	0.000173	CcSEcCtD
Rivastigmine—Dermatitis—Vincristine—kidney cancer	3.2e-05	0.000173	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—kidney cancer	3.19e-05	0.000172	CcSEcCtD
Rivastigmine—Abdominal pain—Paclitaxel—kidney cancer	3.19e-05	0.000172	CcSEcCtD
Rivastigmine—Body temperature increased—Paclitaxel—kidney cancer	3.19e-05	0.000172	CcSEcCtD
Rivastigmine—Headache—Vincristine—kidney cancer	3.18e-05	0.000172	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—MME—kidney cancer	3.17e-05	0.00198	CbGpPWpGaD
Rivastigmine—Hepatobiliary disease—Doxorubicin—kidney cancer	3.17e-05	0.000171	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	3.16e-05	0.00197	CbGpPWpGaD
Rivastigmine—Epistaxis—Doxorubicin—kidney cancer	3.16e-05	0.000171	CcSEcCtD
Rivastigmine—Anorexia—Capecitabine—kidney cancer	3.16e-05	0.000171	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—kidney cancer	3.14e-05	0.00017	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CCBL1—kidney cancer	3.11e-05	0.00195	CbGpPWpGaD
Rivastigmine—Hypotension—Capecitabine—kidney cancer	3.1e-05	0.000167	CcSEcCtD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.09e-05	0.00193	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PTEN—kidney cancer	3.07e-05	0.00192	CbGpPWpGaD
Rivastigmine—Vomiting—Gemcitabine—kidney cancer	3.07e-05	0.000166	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—kidney cancer	3.06e-05	0.000165	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.05e-05	0.00191	CbGpPWpGaD
Rivastigmine—Rash—Gemcitabine—kidney cancer	3.04e-05	0.000164	CcSEcCtD
Rivastigmine—Dermatitis—Gemcitabine—kidney cancer	3.04e-05	0.000164	CcSEcCtD
Rivastigmine—ACHE—Metabolism—PPAT—kidney cancer	3.03e-05	0.00189	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GLIPR1—kidney cancer	3.03e-05	0.00189	CbGpPWpGaD
Rivastigmine—Haemoglobin—Doxorubicin—kidney cancer	3.02e-05	0.000163	CcSEcCtD
Rivastigmine—Headache—Gemcitabine—kidney cancer	3.02e-05	0.000163	CcSEcCtD
Rivastigmine—Nausea—Vincristine—kidney cancer	3.02e-05	0.000163	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.02e-05	0.000163	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—kidney cancer	3.01e-05	0.000163	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—kidney cancer	3.01e-05	0.000162	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—kidney cancer	3.01e-05	0.000162	CcSEcCtD
Rivastigmine—Insomnia—Capecitabine—kidney cancer	3e-05	0.000162	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—kidney cancer	2.99e-05	0.000162	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.99e-05	0.00187	CbGpPWpGaD
Rivastigmine—Pharyngitis—Doxorubicin—kidney cancer	2.98e-05	0.000161	CcSEcCtD
Rivastigmine—Paraesthesia—Capecitabine—kidney cancer	2.97e-05	0.000161	CcSEcCtD
Rivastigmine—Hypersensitivity—Paclitaxel—kidney cancer	2.97e-05	0.000161	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—kidney cancer	2.97e-05	0.00016	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—kidney cancer	2.96e-05	0.00016	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.96e-05	0.00185	CbGpPWpGaD
Rivastigmine—Connective tissue disorder—Doxorubicin—kidney cancer	2.95e-05	0.00016	CcSEcCtD
Rivastigmine—Dyspnoea—Capecitabine—kidney cancer	2.95e-05	0.00016	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—RPL14—kidney cancer	2.95e-05	0.00184	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—HSPD1—kidney cancer	2.95e-05	0.00184	CbGpPWpGaD
Rivastigmine—Urethral disorder—Doxorubicin—kidney cancer	2.95e-05	0.000159	CcSEcCtD
Rivastigmine—Dyspepsia—Capecitabine—kidney cancer	2.92e-05	0.000158	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—kidney cancer	2.9e-05	0.000157	CcSEcCtD
Rivastigmine—Asthenia—Paclitaxel—kidney cancer	2.9e-05	0.000156	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	2.89e-05	0.00181	CbGpPWpGaD
Rivastigmine—Decreased appetite—Capecitabine—kidney cancer	2.88e-05	0.000156	CcSEcCtD
Rivastigmine—Nausea—Gemcitabine—kidney cancer	2.86e-05	0.000155	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Capecitabine—kidney cancer	2.86e-05	0.000155	CcSEcCtD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.86e-05	0.00179	CbGpPWpGaD
Rivastigmine—Fatigue—Capecitabine—kidney cancer	2.86e-05	0.000154	CcSEcCtD
Rivastigmine—Pruritus—Paclitaxel—kidney cancer	2.86e-05	0.000154	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—kidney cancer	2.84e-05	0.000154	CcSEcCtD
Rivastigmine—Pain—Capecitabine—kidney cancer	2.83e-05	0.000153	CcSEcCtD
Rivastigmine—Constipation—Capecitabine—kidney cancer	2.83e-05	0.000153	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.82e-05	0.00176	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—APRT—kidney cancer	2.81e-05	0.00176	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—FH—kidney cancer	2.81e-05	0.00176	CbGpPWpGaD
Rivastigmine—Eye disorder—Doxorubicin—kidney cancer	2.81e-05	0.000152	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.81e-05	0.00175	CbGpPWpGaD
Rivastigmine—Tinnitus—Doxorubicin—kidney cancer	2.8e-05	0.000151	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—kidney cancer	2.79e-05	0.000151	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—kidney cancer	2.79e-05	0.000151	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.78e-05	0.00173	CbGpPWpGaD
Rivastigmine—Diarrhoea—Paclitaxel—kidney cancer	2.76e-05	0.000149	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.75e-05	0.00172	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PTEN—kidney cancer	2.74e-05	0.00171	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Capecitabine—kidney cancer	2.73e-05	0.000148	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—kidney cancer	2.73e-05	0.000147	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.72e-05	0.0017	CbGpPWpGaD
Rivastigmine—Gastrointestinal pain—Capecitabine—kidney cancer	2.71e-05	0.000146	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—kidney cancer	2.71e-05	0.000146	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—RAF1—kidney cancer	2.71e-05	0.00169	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPAT—kidney cancer	2.7e-05	0.00169	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GLIPR1—kidney cancer	2.7e-05	0.00169	CbGpPWpGaD
Rivastigmine—Chills—Doxorubicin—kidney cancer	2.7e-05	0.000146	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.7e-05	0.00168	CbGpPWpGaD
Rivastigmine—Arrhythmia—Doxorubicin—kidney cancer	2.69e-05	0.000145	CcSEcCtD
Rivastigmine—Dizziness—Paclitaxel—kidney cancer	2.67e-05	0.000144	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.67e-05	0.00167	CbGpPWpGaD
Rivastigmine—Alopecia—Doxorubicin—kidney cancer	2.66e-05	0.000144	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GPC3—kidney cancer	2.65e-05	0.00165	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.64e-05	0.00165	CbGpPWpGaD
Rivastigmine—Mental disorder—Doxorubicin—kidney cancer	2.63e-05	0.000142	CcSEcCtD
Rivastigmine—Urticaria—Capecitabine—kidney cancer	2.63e-05	0.000142	CcSEcCtD
Rivastigmine—Body temperature increased—Capecitabine—kidney cancer	2.62e-05	0.000142	CcSEcCtD
Rivastigmine—Abdominal pain—Capecitabine—kidney cancer	2.62e-05	0.000142	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—kidney cancer	2.62e-05	0.000141	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—kidney cancer	2.62e-05	0.000141	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—PAX6—kidney cancer	2.6e-05	0.00162	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CTSD—kidney cancer	2.58e-05	0.00161	CbGpPWpGaD
Rivastigmine—Flatulence—Doxorubicin—kidney cancer	2.58e-05	0.000139	CcSEcCtD
Rivastigmine—ACHE—Metabolism—CA2—kidney cancer	2.57e-05	0.00161	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.57e-05	0.00161	CbGpPWpGaD
Rivastigmine—Tension—Doxorubicin—kidney cancer	2.57e-05	0.000139	CcSEcCtD
Rivastigmine—Vomiting—Paclitaxel—kidney cancer	2.57e-05	0.000139	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—kidney cancer	2.56e-05	0.000138	CcSEcCtD
Rivastigmine—Rash—Paclitaxel—kidney cancer	2.55e-05	0.000138	CcSEcCtD
Rivastigmine—Dermatitis—Paclitaxel—kidney cancer	2.54e-05	0.000137	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—kidney cancer	2.54e-05	0.000137	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—kidney cancer	2.53e-05	0.000137	CcSEcCtD
Rivastigmine—Headache—Paclitaxel—kidney cancer	2.53e-05	0.000137	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—kidney cancer	2.52e-05	0.000136	CcSEcCtD
Rivastigmine—BCHE—Metabolism—FH—kidney cancer	2.51e-05	0.00157	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—APRT—kidney cancer	2.51e-05	0.00157	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALAD—kidney cancer	2.51e-05	0.00157	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.51e-05	0.00157	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—BRAF—kidney cancer	2.48e-05	0.00155	CbGpPWpGaD
Rivastigmine—Vision blurred—Doxorubicin—kidney cancer	2.47e-05	0.000133	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.45e-05	0.00153	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ST3GAL2—kidney cancer	2.45e-05	0.00153	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.45e-05	0.00153	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Capecitabine—kidney cancer	2.44e-05	0.000132	CcSEcCtD
Rivastigmine—BCHE—Metabolism of proteins—ACHE—kidney cancer	2.43e-05	0.00152	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.43e-05	0.00152	CbGpPWpGaD
Rivastigmine—Ill-defined disorder—Doxorubicin—kidney cancer	2.43e-05	0.000131	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—kidney cancer	2.42e-05	0.000131	CcSEcCtD
Rivastigmine—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	2.41e-05	0.00151	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	2.41e-05	0.0015	CbGpPWpGaD
Rivastigmine—Agitation—Doxorubicin—kidney cancer	2.4e-05	0.00013	CcSEcCtD
Rivastigmine—Nausea—Paclitaxel—kidney cancer	2.4e-05	0.00013	CcSEcCtD
Rivastigmine—ACHE—Metabolism—ALDH1A1—kidney cancer	2.39e-05	0.00149	CbGpPWpGaD
Rivastigmine—Asthenia—Capecitabine—kidney cancer	2.38e-05	0.000128	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—BCHE—kidney cancer	2.38e-05	0.00148	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.37e-05	0.00148	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GPC3—kidney cancer	2.36e-05	0.00147	CbGpPWpGaD
Rivastigmine—Malaise—Doxorubicin—kidney cancer	2.36e-05	0.000127	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—kidney cancer	2.35e-05	0.000127	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—kidney cancer	2.35e-05	0.000127	CcSEcCtD
Rivastigmine—Pruritus—Capecitabine—kidney cancer	2.34e-05	0.000127	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	2.34e-05	0.00146	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—PAX6—kidney cancer	2.32e-05	0.00145	CbGpPWpGaD
Rivastigmine—Palpitations—Doxorubicin—kidney cancer	2.31e-05	0.000125	CcSEcCtD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	2.31e-05	0.00144	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.31e-05	0.00144	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CTSD—kidney cancer	2.3e-05	0.00144	CbGpPWpGaD
Rivastigmine—Loss of consciousness—Doxorubicin—kidney cancer	2.3e-05	0.000124	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CA2—kidney cancer	2.3e-05	0.00143	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC5A3—kidney cancer	2.29e-05	0.00143	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PGK1—kidney cancer	2.29e-05	0.00143	CbGpPWpGaD
Rivastigmine—Cough—Doxorubicin—kidney cancer	2.28e-05	0.000123	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—kidney cancer	2.27e-05	0.000122	CcSEcCtD
Rivastigmine—Diarrhoea—Capecitabine—kidney cancer	2.27e-05	0.000122	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—kidney cancer	2.26e-05	0.000122	CcSEcCtD
Rivastigmine—ACHE—Metabolism—LDHB—kidney cancer	2.25e-05	0.00141	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALAD—kidney cancer	2.24e-05	0.0014	CbGpPWpGaD
Rivastigmine—Myalgia—Doxorubicin—kidney cancer	2.23e-05	0.00012	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—kidney cancer	2.23e-05	0.00012	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—kidney cancer	2.23e-05	0.00012	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—kidney cancer	2.22e-05	0.00012	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—BRAF—kidney cancer	2.21e-05	0.00138	CbGpPWpGaD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.21e-05	0.00012	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.21e-05	0.00138	CbGpPWpGaD
Rivastigmine—Discomfort—Doxorubicin—kidney cancer	2.2e-05	0.000119	CcSEcCtD
Rivastigmine—Dizziness—Capecitabine—kidney cancer	2.19e-05	0.000118	CcSEcCtD
Rivastigmine—BCHE—Metabolism—ST3GAL2—kidney cancer	2.18e-05	0.00136	CbGpPWpGaD
Rivastigmine—Dry mouth—Doxorubicin—kidney cancer	2.18e-05	0.000118	CcSEcCtD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CA—kidney cancer	2.17e-05	0.00135	CbGpPWpGaD
Rivastigmine—Confusional state—Doxorubicin—kidney cancer	2.15e-05	0.000116	CcSEcCtD
Rivastigmine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	2.15e-05	0.00134	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.14e-05	0.00134	CbGpPWpGaD
Rivastigmine—Oedema—Doxorubicin—kidney cancer	2.14e-05	0.000115	CcSEcCtD
Rivastigmine—BCHE—Metabolism—ALDH1A1—kidney cancer	2.13e-05	0.00133	CbGpPWpGaD
Rivastigmine—Infection—Doxorubicin—kidney cancer	2.12e-05	0.000115	CcSEcCtD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	2.12e-05	0.00132	CbGpPWpGaD
Rivastigmine—Vomiting—Capecitabine—kidney cancer	2.11e-05	0.000114	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—kidney cancer	2.1e-05	0.000114	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—kidney cancer	2.09e-05	0.000113	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—kidney cancer	2.09e-05	0.000113	CcSEcCtD
Rivastigmine—Rash—Capecitabine—kidney cancer	2.09e-05	0.000113	CcSEcCtD
Rivastigmine—Dermatitis—Capecitabine—kidney cancer	2.09e-05	0.000113	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—kidney cancer	2.08e-05	0.000113	CcSEcCtD
Rivastigmine—Headache—Capecitabine—kidney cancer	2.08e-05	0.000112	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—kidney cancer	2.07e-05	0.000112	CcSEcCtD
Rivastigmine—ACHE—Neuronal System—RAF1—kidney cancer	2.07e-05	0.00129	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.07e-05	0.00129	CbGpPWpGaD
Rivastigmine—Hyperhidrosis—Doxorubicin—kidney cancer	2.06e-05	0.000112	CcSEcCtD
Rivastigmine—BCHE—Metabolism—PGK1—kidney cancer	2.05e-05	0.00128	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC5A3—kidney cancer	2.05e-05	0.00128	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	2.04e-05	0.00127	CbGpPWpGaD
Rivastigmine—Anorexia—Doxorubicin—kidney cancer	2.04e-05	0.00011	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.02e-05	0.00126	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	2.01e-05	0.00125	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—LDHB—kidney cancer	2.01e-05	0.00125	CbGpPWpGaD
Rivastigmine—Hypotension—Doxorubicin—kidney cancer	2e-05	0.000108	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.97e-05	0.00123	CbGpPWpGaD
Rivastigmine—Nausea—Capecitabine—kidney cancer	1.97e-05	0.000106	CcSEcCtD
Rivastigmine—ACHE—Metabolism—CA9—kidney cancer	1.95e-05	0.00122	CbGpPWpGaD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.95e-05	0.000105	CcSEcCtD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	1.93e-05	0.00121	CbGpPWpGaD
Rivastigmine—Insomnia—Doxorubicin—kidney cancer	1.93e-05	0.000104	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.93e-05	0.0012	CbGpPWpGaD
Rivastigmine—Paraesthesia—Doxorubicin—kidney cancer	1.92e-05	0.000104	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.91e-05	0.00119	CbGpPWpGaD
Rivastigmine—Dyspnoea—Doxorubicin—kidney cancer	1.9e-05	0.000103	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—kidney cancer	1.9e-05	0.000103	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—kidney cancer	1.88e-05	0.000102	CcSEcCtD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.87e-05	0.00117	CbGpPWpGaD
Rivastigmine—Decreased appetite—Doxorubicin—kidney cancer	1.86e-05	0.0001	CcSEcCtD
Rivastigmine—ACHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.86e-05	0.00116	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—RAF1—kidney cancer	1.85e-05	0.00116	CbGpPWpGaD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.84e-05	9.96e-05	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—kidney cancer	1.84e-05	9.95e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism of proteins—IGF2—kidney cancer	1.84e-05	0.00115	CbGpPWpGaD
Rivastigmine—Pain—Doxorubicin—kidney cancer	1.83e-05	9.87e-05	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—kidney cancer	1.83e-05	9.87e-05	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.82e-05	0.00114	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ACY1—kidney cancer	1.79e-05	0.00112	CbGpPWpGaD
Rivastigmine—Feeling abnormal—Doxorubicin—kidney cancer	1.76e-05	9.51e-05	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—kidney cancer	1.75e-05	9.44e-05	CcSEcCtD
Rivastigmine—BCHE—Metabolism—CA9—kidney cancer	1.74e-05	0.00109	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.7e-05	0.00106	CbGpPWpGaD
Rivastigmine—Urticaria—Doxorubicin—kidney cancer	1.7e-05	9.17e-05	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—kidney cancer	1.69e-05	9.12e-05	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—kidney cancer	1.69e-05	9.12e-05	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.67e-05	0.00104	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CRABP1—kidney cancer	1.66e-05	0.00104	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	1.66e-05	0.00103	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF2—kidney cancer	1.64e-05	0.00103	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.62e-05	0.00101	CbGpPWpGaD
Rivastigmine—Hypersensitivity—Doxorubicin—kidney cancer	1.57e-05	8.5e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—ITPR2—kidney cancer	1.54e-05	0.000963	CbGpPWpGaD
Rivastigmine—Asthenia—Doxorubicin—kidney cancer	1.53e-05	8.28e-05	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.53e-05	0.000955	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PDHB—kidney cancer	1.52e-05	0.000951	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—POMC—kidney cancer	1.52e-05	0.000949	CbGpPWpGaD
Rivastigmine—Pruritus—Doxorubicin—kidney cancer	1.51e-05	8.16e-05	CcSEcCtD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.51e-05	0.000942	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CRABP1—kidney cancer	1.48e-05	0.000924	CbGpPWpGaD
Rivastigmine—Diarrhoea—Doxorubicin—kidney cancer	1.46e-05	7.89e-05	CcSEcCtD
Rivastigmine—CYP2D6—Metabolism—CCBL1—kidney cancer	1.43e-05	0.000895	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—MAPK1—kidney cancer	1.42e-05	0.000888	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.42e-05	0.000888	CbGpPWpGaD
Rivastigmine—Dizziness—Doxorubicin—kidney cancer	1.41e-05	7.63e-05	CcSEcCtD
Rivastigmine—ACHE—Metabolism—GSTT1—kidney cancer	1.41e-05	0.000878	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.4e-05	0.000877	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.39e-05	0.000865	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ITPR2—kidney cancer	1.38e-05	0.000859	CbGpPWpGaD
Rivastigmine—Vomiting—Doxorubicin—kidney cancer	1.36e-05	7.34e-05	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—kidney cancer	1.35e-05	7.28e-05	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—kidney cancer	1.35e-05	7.27e-05	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—kidney cancer	1.34e-05	7.23e-05	CcSEcCtD
Rivastigmine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.33e-05	0.000832	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SCARB1—kidney cancer	1.33e-05	0.000831	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS1—kidney cancer	1.32e-05	0.000823	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.31e-05	0.00082	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PSMD7—kidney cancer	1.29e-05	0.000807	CbGpPWpGaD
Rivastigmine—Nausea—Doxorubicin—kidney cancer	1.27e-05	6.85e-05	CcSEcCtD
Rivastigmine—BCHE—Neuronal System—MAPK1—kidney cancer	1.27e-05	0.000792	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.27e-05	0.000792	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ACHE—kidney cancer	1.25e-05	0.000784	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTT1—kidney cancer	1.25e-05	0.000784	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPAT—kidney cancer	1.24e-05	0.000776	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.24e-05	0.000776	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—POMC—kidney cancer	1.23e-05	0.000767	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—BCHE—kidney cancer	1.22e-05	0.000765	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC5A5—kidney cancer	1.21e-05	0.000756	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SCARB1—kidney cancer	1.19e-05	0.000742	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS1—kidney cancer	1.18e-05	0.000734	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACY1—kidney cancer	1.17e-05	0.000732	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—SLC2A1—kidney cancer	1.17e-05	0.00073	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—APRT—kidney cancer	1.15e-05	0.000721	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—FH—kidney cancer	1.15e-05	0.000721	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PSMD7—kidney cancer	1.15e-05	0.00072	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.13e-05	0.000708	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—POMC—kidney cancer	1.1e-05	0.000685	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GPC3—kidney cancer	1.09e-05	0.000678	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC5A5—kidney cancer	1.08e-05	0.000674	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CA2—kidney cancer	1.06e-05	0.00066	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—SLC2A1—kidney cancer	1.04e-05	0.000651	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALAD—kidney cancer	1.03e-05	0.000643	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.01e-05	0.000632	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1e-05	0.000627	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PDHB—kidney cancer	9.96e-06	0.000622	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—POMC—kidney cancer	9.93e-06	0.00062	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.89e-06	0.000618	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	9.82e-06	0.000613	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTP1—kidney cancer	9.75e-06	0.000609	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC5A3—kidney cancer	9.41e-06	0.000588	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PGK1—kidney cancer	9.41e-06	0.000588	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CCBL1—kidney cancer	9.36e-06	0.000585	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—LDHB—kidney cancer	9.23e-06	0.000576	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCB1—kidney cancer	9.23e-06	0.000576	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTM1—kidney cancer	8.96e-06	0.00056	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.82e-06	0.000551	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	8.77e-06	0.000548	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTP1—kidney cancer	8.7e-06	0.000543	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1A1—kidney cancer	8.49e-06	0.00053	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCB1—kidney cancer	8.23e-06	0.000514	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.12e-06	0.000507	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPAT—kidney cancer	8.12e-06	0.000507	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CA9—kidney cancer	8e-06	0.0005	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTM1—kidney cancer	7.99e-06	0.000499	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	7.82e-06	0.000489	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1A1—kidney cancer	7.57e-06	0.000473	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—FH—kidney cancer	7.55e-06	0.000471	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—APRT—kidney cancer	7.55e-06	0.000471	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GPC3—kidney cancer	7.1e-06	0.000443	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.98e-06	0.000436	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CA2—kidney cancer	6.9e-06	0.000431	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CRABP1—kidney cancer	6.8e-06	0.000425	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALAD—kidney cancer	6.73e-06	0.00042	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.57e-06	0.00041	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.42e-06	0.000401	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—POMC—kidney cancer	6.33e-06	0.000395	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ITPR2—kidney cancer	6.32e-06	0.000395	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.22e-06	0.000389	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PGK1—kidney cancer	6.15e-06	0.000384	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.15e-06	0.000384	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—LDHB—kidney cancer	6.03e-06	0.000377	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTT1—kidney cancer	5.77e-06	0.00036	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ACHE—kidney cancer	5.77e-06	0.00036	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—POMC—kidney cancer	5.65e-06	0.000353	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SCARB1—kidney cancer	5.46e-06	0.000341	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS1—kidney cancer	5.4e-06	0.000338	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PSMD7—kidney cancer	5.3e-06	0.000331	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CA9—kidney cancer	5.23e-06	0.000327	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTGS2—kidney cancer	5.05e-06	0.000315	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—BCHE—kidney cancer	5.02e-06	0.000314	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.96e-06	0.00031	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.79e-06	0.000299	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTGS2—kidney cancer	4.5e-06	0.000281	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CRABP1—kidney cancer	4.45e-06	0.000278	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PTEN—kidney cancer	4.4e-06	0.000275	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ITPR2—kidney cancer	4.14e-06	0.000258	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—kidney cancer	4e-06	0.00025	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PTEN—kidney cancer	3.93e-06	0.000245	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCB1—kidney cancer	3.78e-06	0.000236	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTT1—kidney cancer	3.77e-06	0.000236	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ACHE—kidney cancer	3.77e-06	0.000236	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM1—kidney cancer	3.67e-06	0.000229	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.57e-06	0.000223	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS1—kidney cancer	3.53e-06	0.000221	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.48e-06	0.000218	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSMD7—kidney cancer	3.47e-06	0.000216	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—BCHE—kidney cancer	3.29e-06	0.000205	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.24e-06	0.000203	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.13e-06	0.000196	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—kidney cancer	3.11e-06	0.000194	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—kidney cancer	2.77e-06	0.000173	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.61e-06	0.000163	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—POMC—kidney cancer	2.6e-06	0.000162	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.47e-06	0.000155	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.4e-06	0.00015	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.28e-06	0.000142	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTGS2—kidney cancer	2.07e-06	0.000129	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PTEN—kidney cancer	1.81e-06	0.000113	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—POMC—kidney cancer	1.7e-06	0.000106	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.35e-06	8.46e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.27e-06	7.96e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PTEN—kidney cancer	1.18e-06	7.38e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.33e-07	5.2e-05	CbGpPWpGaD
